How are energy investors positioned?
David J. Croyle, the Chief Medical (TASE:BLWV) Officer and a significant shareholder of Callan JMB Inc. (NASDAQ:CJMB), recently purchased 24,375 shares of the company’s common stock. The micro-cap company, currently valued at $19.6 million, shows strong financial health with a current ratio of 3.51x and minimal debt levels. The shares were acquired at a price of $4.00 each, bringing the total value of the transaction to $97,500. Following this purchase, Croyle holds 750,000 shares directly, with an additional 24,375 shares held indirectly through Warehouse Asset Management, LLC, in which he has a 39% ownership interest. According to InvestingPro analysis, CJMB’s stock is trading near its Fair Value, with 7 additional exclusive insights available to subscribers, including details on the company’s shareholder yield and volatility patterns.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.